Augmentin for Otitis Media
First-Line Treatment Options
- The American Academy of Pediatrics recommends high-dose amoxicillin (80-90 mg/kg/day in 2 divided doses) as the first-line treatment for most uncomplicated cases of acute otitis media (AOM) due to its effectiveness against common pathogens, safety profile, low cost, and narrow antimicrobial spectrum 1
- For patients who have taken amoxicillin in the previous 30 days, those with concurrent conjunctivitis, or when coverage for Moraxella catarrhalis is specifically desired, high-dose amoxicillin-clavulanate should be used as initial therapy 1
- The recommended dosage for high-dose amoxicillin-clavulanate is 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate (14:1 ratio) given in 2 divided doses 1, 2
Treatment Duration and Response
- Standard treatment duration is typically 10 days 1
- Clinical improvement should be evident within 48-72 hours of initiating appropriate therapy 3
- If no improvement is seen after 48-72 hours, consider treatment failure and switch to an alternative antibiotic regimen 1, 3
Second-Line Options for Treatment Failures
- If initial treatment with amoxicillin fails after 48-72 hours, switching to high-dose amoxicillin-clavulanate is recommended 1
- For patients with penicillin allergies, alternative options include cefdinir (14 mg/kg/day in 1 or 2 doses) 2
- Cefuroxime (30 mg/kg/day in 2 divided doses) is also an alternative option for patients with penicillin allergies 2
- Cefpodoxime (10 mg/kg/day in 2 divided doses) is another alternative option for patients with penicillin allergies 2
Clinical Evidence Supporting Efficacy
- Randomized controlled trials have demonstrated superior efficacy of high-dose amoxicillin-clavulanate compared to azithromycin in eradicating S. pneumoniae (96% vs 80.4%) from the middle ear 1
- A systematic review showed that antibiotics reduce pain at 2-3 days compared to placebo (RR: 0.7), though the number needed to treat to benefit is 20 4
- Amoxicillin-clavulanate has been shown to significantly reduce the time to middle ear effusion disappearance (18.9 days vs 32.6 days) compared to placebo 4
Common Pitfalls and Considerations
- Inadequate dosing of the amoxicillin component when treating potentially resistant organisms is a common pitfall 2
- The 14:1 ratio formulation of amoxicillin-clavulanate is less likely to cause diarrhea than other preparations 1, 2
- While adverse effects are generally mild, they occur more frequently than with placebo (RR: 1.3), with gastrointestinal disturbances being most common 4
- Widespread use of pneumococcal conjugate vaccines (PCV13) may reduce the prevalence of multidrug-resistant pneumococcal serotypes, potentially decreasing the need for high-dose amoxicillin or amoxicillin-clavulanate 1
Amoxicillin-Clavulanate Dosing for Acute Otitis Media with Perforation
Rationale for High-Dose Amoxicillin-Clavulanate
- The American Academy of Pediatrics recommends high-dose amoxicillin-clavulanate for patients with acute otitis media and perforation, as it provides broader coverage against β-lactamase-producing bacteria, with a 14:1 ratio formulation minimizing gastrointestinal side effects 5, 6
- High-dose amoxicillin achieves middle ear fluid concentrations exceeding the minimum inhibitory concentration for approximately 87% of Streptococcus pneumoniae isolates, including intermediately resistant strains, in patients with acute otitis media 5
Specific Dosing Calculation
- The recommended dose of amoxicillin-clavulanate is 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate, divided into 2 doses, which equals approximately 1,710 mg amoxicillin with 121 mg clavulanate twice daily, for a patient with acute otitis media and perforation 5, 6
Treatment Duration and Monitoring
- Clinical improvement should be evident within 48-72 hours; if no improvement occurs, reassess for treatment failure and consider switching to ceftriaxone, according to the American Academy of Pediatrics guidelines 5, 6
- The presence of perforation does not change the antibiotic choice but reinforces the need for high-dose therapy and close follow-up, as recommended by the American Academy of Pediatrics 5
Important Clinical Caveats
- The 14:1 ratio formulation of amoxicillin-clavulanate is critical, as older formulations with higher clavulanate ratios cause significantly more diarrhea, and should be avoided in patients with acute otitis media and perforation 5, 6
- If the patient had received amoxicillin in the previous 30 days, this further supports the choice of amoxicillin-clavulanate over amoxicillin alone, according to the American Academy of Pediatrics guidelines 5, 6
Augmentin Pediatric Dose for Acute Otitis Media
Patient Selection for High-Dose Amoxicillin-Clavulanate
- The American Academy of Pediatrics recommends using high-dose amoxicillin-clavulanate as first-line therapy in children younger than 2 years old, or those who attend daycare, due to increased risk of resistant organisms 7
- The American Academy of Pediatrics also recommends using high-dose amoxicillin-clavulanate in children who have received amoxicillin within the previous 30 days, or have concurrent purulent conjunctivitis, to cover β-lactamase-producing Moraxella catarrhalis or Haemophilus influenzae 7
Dosing and Administration
- The maximum single dose of amoxicillin is 2000 mg, and the dose should be calculated based on the child's weight, with 90 mg/kg/day of the amoxicillin component and 6.4 mg/kg/day of clavulanate, divided into 2 doses daily, using the 14:1 ratio formulation 7
Treatment Failure and Alternative Therapies
- If symptoms do not improve or worsen within 48-72 hours, consider treatment failure and switch to ceftriaxone (50 mg/kg IM/IV), as recommended by the American Academy of Pediatrics 7
Efficacy and Safety
- High-dose amoxicillin-clavulanate demonstrates superior bacterial eradication compared to alternatives, with effective coverage against penicillin-intermediate and resistant S. pneumoniae strains, as well as β-lactamase-producing H. influenzae and M. catarrhalis, according to the American Academy of Pediatrics 7